Why the study?
HFpEF patients have altered myocardial structure and function, but whether patients undergoing elective CABG with HFpEF characteristics show distinctive gene expression compared to those with normal LV physiology was unknown.
Does myocardial gene expression differ in CABG patients with HFpEF characteristics compared to those with normal LV physiology?
Cross-Sectional (n=16)
Does myocardial gene expression differ in CABG patients with HFpEF characteristics compared to those with normal LV physiology?
Answers are grounded in this paper and cite their sources.
Transcriptomic analysis of myocardial biopsies reveals distinct gene expression profiles and regulatory mechanisms in patients with HFpEF characteristics compared to those with normal LV physiology.
Heart failure affects 2-3% of adult Western population. Prevalence of heart failure with preserved left ventricular (LV) ejection fraction (HFpEF) increases. Studies suggest HFpEF patients to have altered myocardial structure and functional changes such as incomplete relaxation and increased cardiac stiffness. We hypothesised that patients undergoing elective coronary bypass surgery (CABG) with HFpEF characteristics would show distinctive gene expression compared to patients with normal LV physiology. Myocardial biopsies for mRNA expression analysis were obtained from sixteen patients with LV ejection fraction ≥45%. Five out of 16 patients (31%) had echocardiographic characteristics and increased NTproBNP levels indicative of HFpEF and this group was used as HFpEF proxy, while 11 patients had Normal LV physiology. Utilising principal component analysis, the gene expression data clustered into two groups, corresponding to HFpEF proxy and Normal physiology, and 743 differentially expressed genes were identified. The associated top biological functions were cardiac muscle contraction, oxidative phosphorylation, cellular remodelling and matrix organisation. Our results also indicate that upstream regulatory events, including inhibition of transcription factors STAT4, SRF and TP53, and activation of transcription repressors HEY2 and KDM5A, could provide explanatory mechanisms to observed gene expression differences and ultimately cardiac dysfunction in the HFpEF proxy group.
No takes yet. Share an insight, caveat, or question.
Das et al. (2019) conducted a cross-sectional in Heart failure with preserved ejection fraction (HFpEF) (n=16). HFpEF proxy characteristics vs. Normal LV physiology was evaluated on Differentially expressed genes (DEGs) between HFpEF proxy and Normal physiology.
Synapse has enriched 10 related papers. Consider them for comparative context: